Scientists react to US flu plan

Critics say there are many holes left to fill; U.S. government defends proposal

Written byMelissa Lee Phillips
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientists from across the country are weighing in on the US avian flu plan, including the Center for Biosecurity at the University of Pittsburgh Medical Center (UPMC), which released a detailed critique outlining potential problems in case of a pandemic less than a week after the Department of Health and Human Services (HHS) released its 400-page, $7.1 billion plan.

While "the government's efforts so far are an important and serious beginning" to addressing the potential pandemic, the HHS plan "does not convey yet with nearly enough clarity how we're going to resolve the most critical issues," according to Thomas Inglesby, COO and director of the Center for Biosecurity at UPMC.

Other scientists agreed that some details of the plan need a closer look. The plan deserves support, but "it needs fine-tuning," Arnold Monto, professor of epidemiology at the University of Michigan School of Public Health in Ann Arbor, told The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform